Mediators of Inflammation

Mediators of Inflammation / 1993 / Article

Open Access

Volume 2 |Article ID 289547 | https://doi.org/10.1155/S0962935193000067

E. F. Morand, D. Rickard, N. J. Goulding, "Lack of involvement of lipocortin 1 in dexamethasone suppression of IL-1 release", Mediators of Inflammation, vol. 2, Article ID 289547, 4 pages, 1993. https://doi.org/10.1155/S0962935193000067

Lack of involvement of lipocortin 1 in dexamethasone suppression of IL-1 release

Received24 Nov 1992
Accepted01 Dec 1992

Abstract

The annexin lipocortin 1 is reported to mediate some anti-inflammatory effects of glucocorticoids, but the mechanisms of this mediation are incompletely understood. The involvement of lipocortin 1 in glucocorticoid inhibition of monocyte interleukin 1β (IL-1β) release has been investigated. Treatment of peripheral blood monocytes with 2 μg/ml lipopolysaccharide potently increased IL–1β release (p = 0.001) and dexamethasone (10−7 M) significantly reduced both resting and stimulated IL-1β release (p = 0.009). A neutralizing monoclonal antibody to lipocortin 1 (0.5–50.0 μg/ml) was unable to inhibit this effect and recombinant lipocortin 1 (2 × 10−6 M) and 188aa lipocortin 1 fragment (10−8−10−6 M) had no effect. It is concluded that lipocortin 1 is not involved in the inhibition of monocyte IL-1β release by glucocorticoids.

Copyright © 1993 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

No related content is available yet for this article.
 PDF Download Citation Citation
 Order printed copiesOrder
Views136
Downloads366
Citations

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.